We are live on
!
Find out more
HCM
Hayman Capital Management Portfolio holdings
AUM
$63.3M
1-Year Est. Return
3.78%
This Fund
S&P 500
This Quarter
Est. Return
-25.42%
1 Year Est. Return
-3.78%
3 Year Est. Return
-44.06%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$44.6M
AUM Growth
-$35.6M
(-44%)
Cap. Flow
-$21.5M
Cap. Flow
% of AUM
-48.15%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$2.12M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 83.51% |
| 2 | Energy | 12.19% |
| 3 | Healthcare | 4.31% |
Similar funds
LVP
PVMCI
SVP
HWM
CCG
CSM
KCP
EL
Hayman Capital Management's Q1 2016 Portfolio in Review
As of Q1 2016, Hayman Capital Management held 4 positions worth $44.6M, down 44% from $80.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Hayman Capital Management withdrew a net $21.5M in Q1 2016, closing 1 position.
By sector, the portfolio is most concentrated in Financials at 84% of assets, up from 62% a quarter earlier, followed by Energy and Healthcare.
Against the trend, Hayman Capital Management opened a new position in Clovis Oncology, Inc. worth $1.92M.
- Hayman Capital Management's largest Q1 2016 buy was Clovis Oncology, Inc.: 100,000 shares worth $1.92M.
- Hayman Capital Management's ten largest holdings make up 100% of its $44.6M portfolio in Q1 2016.
- Hayman Capital Management opened 1 new position and closed 1 in Q1 2016.
- Hayman Capital Management's portfolio value fell 44% quarter-over-quarter to $44.6M.
Based on Hayman Capital Management's 13F filing for Q1 2016, filed 16 May 2016.